ijms-logo

Journal Browser

Journal Browser

Dopamine Neurons and the Genetic Pharmacology of Addiction: Unraveling Molecular Pathways

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".

Deadline for manuscript submissions: 30 September 2024 | Viewed by 225

Special Issue Editor


E-Mail Website
Guest Editor
Department of Hygiene and Epidemiology, Collegium Medicum, University of Zielona Góra, 28 Zyty St., 65-046 Zielona Góra, Poland
Interests: addiction genetics; public health specialist
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

We understand that addictive behavior seeking is a multi-faceted neurobiological, genetic, epigenetic, personality and spiritual phenomenon, which proves that addictions are not one-dimensional and their occurrence requires currently unknown accompanying factors.

Evidence of a significant degree of inheritance in all types of addictions has led to attempts to identify specific genes. Research is complicated by the fact that addictive behaviors are a complex trait that is heterogeneous in terms of phenotype and genetics. It is believed that the profile of symptoms and the variety of observed behaviors are influenced by numerous gene loci, which differ in the direction of influence and the intensity of the effect. The possibilities of understanding the genetic basis of addiction are further complicated by interactions between different loci (epistasis) and gene–environment interactions. Therefore, although substance abuse and addiction undoubtedly depend on genetic factors, the genetic cross-section of these disorders is more complicated than in the case of traits inherited according to Mendel’s laws.

Advances in genome technology are increasing the ability to unravel many of the complex aspects of substance use disorders, including the role of low-effect genes, and to consider gene–environment interactions. It is hoped that in the future, discoveries made through the use of gene identification techniques combined with the results of functional, developmental, and pharmacological studies of the identified genes will lead to progress in the field of addiction prevention and treatment.

This Special Issue is supervised by Dr. Jolanta Chmielowiec, assisted by our Topical Advisory Panel Member Dr. Kszysztof Chmielowiec (University of Zielona Góra).

Dr. Jolanta Chmielowiec
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • dopamine
  • neurons
  • addiction
  • gene
  • personality traits
  • molecular mechanisms

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

14 pages, 364 KiB  
Article
Analysis of the BDNF Gene rs6265 Polymorphism in a Group of Women with Alcohol Use Disorder, Taking into Account Personality Traits
by Agnieszka Boroń, Aleksandra Suchanecka, Krzysztof Chmielowiec, Jolanta Chmielowiec, Jolanta Masiak, Grzegorz Trybek, Aleksandra Strońska-Pluta, Monika Rychel and Anna Grzywacz
Int. J. Mol. Sci. 2024, 25(12), 6448; https://doi.org/10.3390/ijms25126448 - 11 Jun 2024
Viewed by 124
Abstract
It seems that BDNF has a direct influence on the brain pathways and is typically engaged during the processing of rewards. A surge in BDNF levels in the ventral tegmental area (the region from which the dopaminergic neurons of the mesocorticolimbic dopamine system [...] Read more.
It seems that BDNF has a direct influence on the brain pathways and is typically engaged during the processing of rewards. A surge in BDNF levels in the ventral tegmental area (the region from which the dopaminergic neurons of the mesocorticolimbic dopamine system originate and extend to the dorsolateral and ventromedial striatum) triggers a state of reward similar to that produced by opiates in animal studies. The aims of the study were (1) to analyze the association of the BDNF gene rs6265 polymorphism with AUD (alcohol use disorder) in women, (2) analyze personality and anxiety in alcohol-dependent and control woman, and (3) conduct an interaction analysis of rs6265 on personality, anxiety, and alcohol dependence. Our study found a notable interaction between the anxiety (trait and state), neuroticism, rs6265, and AUD. The alcohol AUD G/A genotype carriers revealed higher level of the anxiety trait (p < 0.0001) and neuroticism (p < 0.0001) compared to the control group with G/A and G/G genotypes. The alcohol use disorder subjects with the G/A genotype displayed higher levels of an anxiety state than the control group with G/A (p < 0.0001) and G/G (p = 0.0014) genotypes. Additionally, the alcohol use disorder subjects with the G/G genotype obtained lower levels of agreeability compared to the controls with G/A (p < 0.0001) and G/G (p < 0.0001) genotypes. Our study indicates that anxiety (trait and state) and neuroticism are interacting with the BDNF gene rs6265 polymorphism in alcohol-dependent women. Characteristics like anxiety (both as a trait and a state) and neuroticism could have a significant impact on the mechanism of substance dependency, particularly in females who are genetically susceptible. This is regardless of the reward system that is implicated in the emotional disruptions accompanying anxiety and depression. Full article
Back to TopTop